Agios Pharmaceuticals
AGIO
#3931
Rank
โ‚ฌ2.28 B
Marketcap
40,21ย โ‚ฌ
Share price
3.95%
Change (1 day)
83.65%
Change (1 year)

Revenue for Agios Pharmaceuticals (AGIO)

Revenue in 2024 (TTM): โ‚ฌ27.17 Million

According to Agios Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ27.05 Million. In 2023 the company made a revenue of โ‚ฌ24.26 Million an increase over the revenue in the year 2022 that were of โ‚ฌ13.27 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Agios Pharmaceuticals from 2012 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ27.17 M11.99%
2023 โ‚ฌ24.26 M82.78%
2022 โ‚ฌ13.27 M
2021 N/A-100%
2020 โ‚ฌ35.8 M-65.98%
2019 โ‚ฌ0.10 B27.57%
2018 โ‚ฌ82.5 M130.16%
2017 โ‚ฌ35.84 M-46.05%
2016 โ‚ฌ66.44 M22.89%
2015 โ‚ฌ54.06 M0.61%
2014 โ‚ฌ53.73 M190.49%
2013 โ‚ฌ18.49 M-2.53%
2012 โ‚ฌ18.97 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ0.12 B 354.44%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.85 B 6,749.56%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ51.20 B 189,139.19%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.38 B 8,703.18%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ36.31 B 134,127.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ35.81 B 132,276.97%๐Ÿ‡บ๐Ÿ‡ธ USA